Yu-Chin Chen Selected Research

Yu-Chin Chen Research Topics

3	Infections 09/2022 - 01/2020
2	Non-ST Elevated Myocardial Infarction 01/2024 - 01/2023
2	ST Elevation Myocardial Infarction 01/2024 - 01/2023
2	Inflammation (Inflammations) 04/2021 - 01/2017
2	Mycoplasma Pneumonia 04/2021 - 01/2020
2	Fever (Fevers) 04/2021 - 01/2020
1	Intraabdominal Infections 01/2023
1	Stroke (Strokes) 01/2023
1	Pneumonia (Pneumonitis) 01/2020
1	Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide) 11/2019
1	Necrosis 11/2019
1	Acute Kidney Injury (Acute Renal Failure) 01/2016
1	Type 2 Diabetes Mellitus (MODY) 12/2015
1	Sepsis (Septicemia) 08/2015
1	Urinary Tract Infections (Urinary Tract Infection) 08/2015

2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 04/2021
2	MacrolidesIBA 04/2021 - 01/2020
2	Charcoal (Charbon)IBA 11/2019 - 01/2016
1	Cefepime (Maxipime)FDA LinkGeneric 01/2023
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2023
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2023
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2023
1	Antiviral Agents (Antivirals)IBA 09/2022
1	Prednisolone (Predate)FDA LinkGeneric 04/2021
1	Bicarbonates (Hydrogen Carbonate)IBA 11/2019
1	hylanIBA 01/2017
1	Hyaluronic Acid (Hyaluronan)IBA 01/2017
1	Pyruvaldehyde (Methylglyoxal)IBA 12/2015
1	Glyoxal (Ethanedial)IBA 12/2015
1	Hemoglobins (Hemoglobin)IBA 12/2015

2	Percutaneous Coronary Intervention 01/2024 - 01/2023
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2024 - 01/2023
1	Patient Readmission 01/2023
1	Therapeutics 09/2022
1	Treatment Delay 04/2021
1	Hyperbaric Oxygenation 11/2019
1	Ventilator Weaning 08/2015
1	Medication Errors (Medication Error) 08/2015